OTCMKTS:CBIS Cannabis Science (CBIS) Stock Price, News & Analysis → We’ve Made 1,000% … THREE Different Times in the Last Year (Here’s How) (From Paradigm Press) (Ad) Free CBIS Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$0.0050▼$0.005050-Day Range$0.0050▼$0.005052-Week Range$0.00▼$0.06VolumeN/AAverage Volume4.85 million shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Cannabis Science alerts: Email Address Ad Porter & CompanySecret energy grid to power millions of homesThis high-security, secret U.S. facility has 2,100 engineers, machinists, and technicians building a new type of energy system the world has never seen before.Click here to get all the details. About Cannabis Science Stock (OTCMKTS:CBIS)Cannabis Science, Inc., together with its subsidiaries, develops, produces, and commercializes phytocannabinoid-based pharmaceutical products primarily in the United States. The company is developing medicines for autism, blood pressure, cancer, cancer side effects, and other illnesses, as well as for general health maintenance. Its drugs under development include CS-TATI-1 for newly diagnosed and treatment-experienced patients with drug-resistant HIV strains, as well as those intolerant of available therapies; CS-S/BCC-1 to treat basal and squamous cell carcinomas; and a proprietary cannabis-based therapy for neurological conditions. In addition, the company offers an online video-based medical cannabis education system, including courses, such as medical cannabis law, benefits of medical marijuana, cooking, horticulture, and bud tending; and manufactures and distributes specialty horse and pet grooming and topical applications. It has collaboration with IGXBio, Inc. to develop GenePro, a DNA-based immunotherapeutic drug; and a research collaboration agreement with Dana-Farber Cancer Institute, Inc. to develop and investigate the use of cannabinoids to cure various cancers, as well as with Stellenbosch University to treat chronic pelvic pain associated with pelvic inflammatory disease in women, chronic prostatitis in men, and other chronic pain associated with other indications. The company was formerly known as Gulf Onshore, Inc. and changed its name to Cannabis Science, Inc. in April 2009. The company was incorporated in 1996 and is based in Irvine, California. Cannabis Science, Inc. is a subsidiary of Weedmaps Media, Inc.Read More Ad Porter & CompanySecret energy grid to power millions of homesThis high-security, secret U.S. facility has 2,100 engineers, machinists, and technicians building a new type of energy system the world has never seen before.Click here to get all the details. CBIS Stock News HeadlinesMay 22, 2024 | msn.comEvidence suggests link between teen cannabis use and psychotic disorders may be stronger than previously thoughtMay 21, 2024 | msn.comBig Weed: Consolidation is changing the face of California cannabisMay 20, 2024 | nytimes.comDoes Legalizing Cannabis Increase Adolescent Use? This Expert Found Mixed Results.May 20, 2024 | msn.comStudy Finds High-Strength Cannabis Doubles Risks of Psychosis in Teen Years : ScienceAlertMay 14, 2024 | yahoo.comCouncil passes first reading of short-term moratorium on cannabis, tobacco, liquor and sexually-oriented businessesMay 14, 2024 | forbes.comSmoking Safer Through Science, Weedgets DemonstratesMay 13, 2024 | msn.comCannabis compound’s neuroprotective properties revealed — could be key to treating Alzheimer’s and Parkinson’sMay 10, 2024 | msn.comHealth risks of using cannabis are higher in adolescents than in adults, study findsMay 10, 2024 | msn.comHow cannabis and psilocybin might help some of the 50 million Americans who are experiencing chronic painMay 8, 2024 | msn.comCannabis Ages Brain By Almost 3 Years, Study ClaimsMay 1, 2024 | yahoo.comReclassifying cannabis holds serious science potential — but hurdles remainMay 1, 2024 | msn.comPending US Revision of Cannabis Drug Classification Announced: ScienceAlertApril 30, 2024 | msn.comUS to reclassify cannabis as low-risk drug, in major shiftApril 28, 2024 | msn.comScientists find cannabis won’t make you ‘lazy & unmotivated’, but it can make you less reliableApril 24, 2024 | msn.comThis Pioneering Cannabis Graduate Program Is A Blend Of Social Work And Marijuana, Here's Why Students Should ApplyApril 22, 2024 | dailymail.co.ukWhat smoking cannabis really does to your mind: Experts reveal the surprising effects this 4/20 - from boosting your libido to triggering auditory illusionsApril 20, 2024 | msn.comHouston ranks 6th worldwide for cannabis consumption, new report saysApril 20, 2024 | msn.comIs cannabis actually green? Experts unpack the climate impacts of weed's rising popularityApril 19, 2024 | time.comChurch Offers Support for Cannabis Users on 4/20April 19, 2024 | forbes.comThe Cannabis Civil War: Hemp vs. MarijuanaApril 19, 2024 | msn.comMSU Denver launches new Cannabis Hospitality Certificate programsApril 18, 2024 | msn.comNew cannabis studies courses coming to Jacksonville State UniversityApril 18, 2024 | msn.comWidespread Cannabis Use Falls From Its Pandemic HighApril 17, 2024 | yahoo.comNew study shows which states have the cheapest high-quality cannabis. Here’s how WA rankedApril 16, 2024 | msn.comAround 27% of individuals with ADHD develop cannabis use disorder at some point in their lives, study findsSee More Headlines Receive CBIS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cannabis Science and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings7/28/2015Today6/07/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryCannabis Current SymbolOTCMKTS:CBIS CUSIP137648101 CIK1024626 Webwww.cannabisscience.com Phone+1-888-8890888FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 7 Stocks to Own Before the 2024 ElectionLooking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.Get This Free Report Key ExecutivesMr. Raymond C. Dabney (Age 54)Co-Founder, Chairman, CEO & Pres Mr. Benjamin C. K. Tam (Age 67)CFO, Sec. & Director Mr. Robert James Kane (Age 43)COO & Director Mr. Mario Lap (Age 67)Pres of European Operations & Director Mr. Bret BogueDirector of Horticulture and Head of R&DKey Competitors1PM IndustriesOTCMKTS:OPMZAcquired SalesOTCMKTS:AQSPAmerican CannabisOTCMKTS:AMMJAmeriCannOTCMKTS:ACANCannabis SativaOTCMKTS:CBDSView All Competitors CBIS Stock Analysis - Frequently Asked Questions How were Cannabis Science's earnings last quarter? Cannabis Science Inc (OTCMKTS:CBIS) posted its quarterly earnings results on Tuesday, July, 28th. The company reported $0.00 earnings per share for the quarter. What other stocks do shareholders of Cannabis Science own? Based on aggregate information from My MarketBeat watchlists, some companies that other Cannabis Science investors own include Medical Marijuana (MJNA), Unrivaled Brands (TRTC), Hemp (HEMP), Aurora Cannabis (ACBFF), Cronos Group (CRON), KushCo (KSHB) and Energous (WATT). This page (OTCMKTS:CBIS) was last updated on 6/8/2024 by MarketBeat.com Staff From Our PartnersMillionaire-Making “Wealth Pattern” Just Repeated on April 22If you think you missed out on the Bitcoin band wagon… You need to watch this immediately.Paradigm Press | SponsoredBreaking - The US Gov. Seized CITGODo you want an investment that can double or triple your money in the next three months? The US Court is cu...Augury Research | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredAI Hell Will Break Loose [June 30, 2024] …On June 30, 2024, AI will reach a critical tipping point… Whatever you do, make sure you prepare before Ju...Banyan Hill Publishing | SponsoredWas the Great Financial Crisis fun?The Great Financial Crisis, which actually started in the summer of 2007 and did not end until March of 2009, ...Brooks Enterprises | SponsoredCollapse of the Petrodollar The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cannabis Science Inc Please log in to your account or sign up in order to add this asset to your watchlist. Share Cannabis Science With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.